Member Info for beinthelead

Nice statement.

“The UK’s world-leading science needs to be supported to deliver long term societal and shareholder value in the UK.”

Or simpler; He’s fed up with his current incompetent advisors. He’s made that unequivocally clear.

Time to move on.

Crowfoot - comment section; letter to the editor.

Great find, thanks. I think this a hugely important signal as to what’s about to happen. AS gives nothing away (much to my annoyance).

This is heart on sleeve stuff - they’re taking his ‘rare unicorn’ over the pond. He’s stolen unicorn from me, but I’ll gloss over.

So; Rip and Cella Boy are correct. NASDAQ looks like the imminent move. He blames the ‘paucity of expert analysts to guide risk-averse UK investment managers’ this aggregates AIM in general for me. Those rubbish notes by TD, poor II investment…

Might explain some of the speeding tickets on 17th? The board and recent hires are very much experienced in wares across the pond.

Anyway - great find.

AEs are expected, very rarely (never seen a single trial) where there wasn’t at least a grade 2. Most often have grade 3s. That’s why I’m so intrigued by the ‘Chemo without…’ line. If they have grade 1/2 AEs, it’s unicorn stuff.

The MTD thing is a quite binary in that they were likely hitting one, or could go mental. Looks like they’re going to go mental.

4D is no comparison to AVCT. Although most do suggest it.

I’m on the NASDAQ thing. Good call - not too familiar with the mechanics, but got to happen.

This market can’t be any worse. They haven’t a clue.

JT - fair view.

“Science Day to include presentation of the data emerging from the phase 1a clinical trial of AVA6000”

I’m expecting this.

We’ll get the data in format appropriate for the science day. They’re obliged, almost duty bound to do that. It’s an opp to sing from the roof tops - they’ve gone with detailed preso’s to date, this shouldn’t change.

Good POV on insiti’s - most believe it’s Avacta chasing them for cash?? Might it be the other way round??! Good call.

No reason to believe it’s mistimed. Why would it? No odd deadlines to hold. The 17th RNS provided the mitigation against a delay slide in the SP. The science day, oddly, is a ‘random’ event.

I’m not overly bothered when and where they present, but I want/need to see the data. There’s no reason for it to be withheld. And no, an incomplete P1a is not a reason. Nor is ethics.

They’re presenting it on the 23rd hence my excitement for the day. The chats with funds is a bonus.

Good post. Nice to see no conspiracy theory or ancient rampy video. Plain, honest goodness.

Agreed.

Agreed.

Derek and Thompi. Eggy and Wyn. The crew.

And yes, Rip’s assessment was bang on. Once again; like every single one of your objective comments - please provide evidence and reasoning.

Still waiting for Derek’s investment case.

https://twitter.com/tom_the_bomb__/status/1619259913758441473?s=46&t=XqWP0h6Ix7DEmzxEwHzzRg

Ancient video and ramps Al is on his stage… science set up for some commercials. After all, he’s lined them up.

“If I were you lot I'd calm down a bit.“

This can be prosecuted under the Malicious Communication Act 1988 and the Communications Act 2003. Online threats could take many forms including threats to kill, harm or to commit an offence against a person, group of people or organisation.

Over to you Wyn, what ya gonna do?

It’s all small. Always enough that’s you’re happy to lose.

D-Geeman. Nothing personal, I believe you are wyn.

You followed Wyn are you are Wyn???

Still waiting on Derek explains how and why it could rise. He’s a holder.

Thanks Derek.

I know. Could afford any more. I’d have asked Myles, but he’s gone all in.